vTv Therapeutics (VTVT) Preferred Shares Issued (2022 - 2024)
vTv Therapeutics' (VTVT) quarterly Preferred Shares Issued came in at -$50.3 million in Q4 2024, down 200.0% quarter-over-quarter from $50.3 million in Q1 2024.
vTv Therapeutics (VTVT) Preferred Shares Issued (2022 - 2024) Analysis & Trends
vTv Therapeutics has disclosed Preferred Shares Issued across 2 years of filings, most recently posting -$50.3 million for Q4 2024.
- Preferred Shares Issued for Q4 2024 came in at -$50.3 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was -$50.3 million (down 200.0% YoY), and the FY2022 annual result was $9.7 million, changed N/A from the prior year.
- Preferred Shares Issued came in at -$50.3 million for Q4 2024 at vTv Therapeutics, down from $50.3 million in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $50.3 million in Q1 2024 to a low of -$50.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | vTv Therapeutics | 426.76 Mn | 426.76 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -50.34 Mn |
| Dec 31, 2024 | -50.34 Mn |
| Mar 31, 2024 | 50.34 Mn |
| Mar 31, 2024 | 50.34 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Dec 31, 2022 | 4.00 Mn |